BRIDGES: A phase 3 randomized trial of immediate postoperative cesium-131 tile-based radiation therapy followed by abbreviated chemoradiation for newly diagnosed glioblastoma (NCT07195591).
Clark C. Chen, Rohil Shekher, Brijal Desai, Andrew Kopecky et autres
TPS2105 Background: Glioblastoma remains a lethal primary brain tumor with limited therapeutic progress and a persistent unmet clinical need. Standard management requires maximal safe resection followed by external beam radiation therapy (EBRT) with concurrent temozolomide (TMZ); however, the required 4–6-week postoperative healing …
us (code pays fourni par la source)